IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-42178-6.html
   My bibliography  Save this article

Inhibiting stromal Class I HDACs curbs pancreatic cancer progression

Author

Listed:
  • Gaoyang Liang

    (Salk Institute for Biological Studies)

  • Tae Gyu Oh

    (Salk Institute for Biological Studies
    University of Oklahoma Health Sciences Center)

  • Nasun Hah

    (Salk Institute for Biological Studies)

  • Hervé Tiriac

    (University of California San Diego)

  • Yu Shi

    (Salk Institute for Biological Studies
    Bristol Myer Squibb)

  • Morgan L. Truitt

    (Salk Institute for Biological Studies)

  • Corina E. Antal

    (Salk Institute for Biological Studies
    University of California San Diego)

  • Annette R. Atkins

    (Salk Institute for Biological Studies)

  • Yuwenbin Li

    (Salk Institute for Biological Studies)

  • Cory Fraser

    (HonorHealth Scottsdale Osborn Medical Center and Shea Medical Center)

  • Serina Ng

    (The Translational Genomic Research Institute)

  • Antonio F. M. Pinto

    (Salk Institute for Biological Studies)

  • Dylan C. Nelson

    (Salk Institute for Biological Studies)

  • Gabriela Estepa

    (Salk Institute for Biological Studies)

  • Senada Bashi

    (Salk Institute for Biological Studies)

  • Ester Banayo

    (Salk Institute for Biological Studies)

  • Yang Dai

    (Salk Institute for Biological Studies)

  • Christopher Liddle

    (University of Sydney, Westmead Hospital)

  • Ruth T. Yu

    (Salk Institute for Biological Studies)

  • Tony Hunter

    (Salk Institute for Biological Studies)

  • Dannielle D. Engle

    (Salk Institute for Biological Studies)

  • Haiyong Han

    (The Translational Genomic Research Institute)

  • Daniel D. Von Hoff

    (HonorHealth Scottsdale Osborn Medical Center and Shea Medical Center
    The Translational Genomic Research Institute)

  • Michael Downes

    (Salk Institute for Biological Studies)

  • Ronald M. Evans

    (Salk Institute for Biological Studies)

Abstract

Oncogenic lesions in pancreatic ductal adenocarcinoma (PDAC) hijack the epigenetic machinery in stromal components to establish a desmoplastic and therapeutic resistant tumor microenvironment (TME). Here we identify Class I histone deacetylases (HDACs) as key epigenetic factors facilitating the induction of pro-desmoplastic and pro-tumorigenic transcriptional programs in pancreatic stromal fibroblasts. Mechanistically, HDAC-mediated changes in chromatin architecture enable the activation of pro-desmoplastic programs directed by serum response factor (SRF) and forkhead box M1 (FOXM1). HDACs also coordinate fibroblast pro-inflammatory programs inducing leukemia inhibitory factor (LIF) expression, supporting paracrine pro-tumorigenic crosstalk. HDAC depletion in cancer-associated fibroblasts (CAFs) and treatment with the HDAC inhibitor entinostat (Ent) in PDAC mouse models reduce stromal activation and curb tumor progression. Notably, HDAC inhibition (HDACi) enriches a lipogenic fibroblast subpopulation, a potential precursor for myofibroblasts in the PDAC stroma. Overall, our study reveals the stromal targeting potential of HDACi, highlighting the utility of this epigenetic modulating approach in PDAC therapeutics.

Suggested Citation

  • Gaoyang Liang & Tae Gyu Oh & Nasun Hah & Hervé Tiriac & Yu Shi & Morgan L. Truitt & Corina E. Antal & Annette R. Atkins & Yuwenbin Li & Cory Fraser & Serina Ng & Antonio F. M. Pinto & Dylan C. Nelson , 2023. "Inhibiting stromal Class I HDACs curbs pancreatic cancer progression," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-42178-6
    DOI: 10.1038/s41467-023-42178-6
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-42178-6
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-42178-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Lars Ny & Henrik Jespersen & Joakim Karlsson & Samuel Alsén & Stefan Filges & Charlotta All-Eriksson & Bengt Andersson & Ana Carneiro & Hildur Helgadottir & Max Levin & Ingrid Ljuslinder & Roger Olofs, 2021. "The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma," Nature Communications, Nature, vol. 12(1), pages 1-10, December.
    2. Matthew B. Buechler & Rachana N. Pradhan & Akshay T. Krishnamurty & Christian Cox & Aslihan Karabacak Calviello & Amber W. Wang & Yeqing Angela Yang & Lucinda Tam & Roger Caothien & Merone Roose-Girma, 2021. "Cross-tissue organization of the fibroblast lineage," Nature, Nature, vol. 593(7860), pages 575-579, May.
    3. Akshay T. Krishnamurty & Justin A. Shyer & Minh Thai & Vineela Gandham & Matthew B. Buechler & Yeqing Angela Yang & Rachana N. Pradhan & Amber W. Wang & Patricia L. Sanchez & Yan Qu & Beatrice Breart , 2022. "LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity," Nature, Nature, vol. 611(7934), pages 148-154, November.
    4. Yu Shi & Weina Gao & Nikki K. Lytle & Peiwu Huang & Xiao Yuan & Amanda M. Dann & Maya Ridinger-Saison & Kathleen E. DelGiorno & Corina E. Antal & Gaoyang Liang & Annette R. Atkins & Galina Erikson & H, 2019. "Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring," Nature, Nature, vol. 569(7754), pages 131-135, May.
    5. Man-Tzu Wang & Nicole Fer & Jacqueline Galeas & Eric A. Collisson & Sung Eun Kim & Jeremy Sharib & Frank McCormick, 2019. "Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer," Nature Communications, Nature, vol. 10(1), pages 1-10, December.
    6. Kristin C. Hicks & Paul L. Chariou & Yohei Ozawa & Christine M. Minnar & Karin M. Knudson & Thomas J. Meyer & Jing Bian & Margaret Cam & Jeffrey Schlom & Sofia R. Gameiro, 2021. "Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape," Nature Communications, Nature, vol. 12(1), pages 1-18, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Lisa Veghini & Davide Pasini & Rui Fang & Pietro Delfino & Dea Filippini & Christian Neander & Caterina Vicentini & Elena Fiorini & Francesca Lupo & Sabrina L. D’Agosto & Carmine Carbone & Antonio Ago, 2024. "Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    2. Hugo Croizer & Rana Mhaidly & Yann Kieffer & Geraldine Gentric & Lounes Djerroudi & Renaud Leclere & Floriane Pelon & Catherine Robley & Mylene Bohec & Arnaud Meng & Didier Meseure & Emanuela Romano &, 2024. "Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer," Nature Communications, Nature, vol. 15(1), pages 1-28, December.
    3. Marina T. Broz & Emily Y. Ko & Kristin Ishaya & Jinfen Xiao & Marco Simone & Xen Ping Hoi & Roberta Piras & Basia Gala & Fernando H. G. Tessaro & Anja Karlstaedt & Sandra Orsulic & Amanda W. Lund & Ke, 2024. "Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    4. Fabian Peisker & Maurice Halder & James Nagai & Susanne Ziegler & Nadine Kaesler & Konrad Hoeft & Ronghui Li & Eric M. J. Bindels & Christoph Kuppe & Julia Moellmann & Michael Lehrke & Christian Stopp, 2022. "Mapping the cardiac vascular niche in heart failure," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    5. Yu Feng & Wenjuan Ma & Yupeng Zang & Yanying Guo & Young Li & Yixuan Zhang & Xuan Dong & Yi Liu & Xiaojuan Zhan & Zhizhong Pan & Mei Luo & Miaoqing Wu & Ao Chen & Da Kang & Gong Chen & Longqi Liu & Ji, 2024. "Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    6. Amir Dailamy & Weiqi Lyu & Sami Nourreddine & Michael Tong & Joseph Rainaldi & Daniella McDonald & Rebecca Panwala & Alysson Muotri & Michael S. Breen & Kun Zhang & Prashant Mali, 2024. "Charting and probing the activity of ADARs in human development and cell-fate specification," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    7. Martin Uhrbom & Lars Muhl & Guillem Genové & Jianping Liu & Henrik Palmgren & Ida Alexandersson & Fredrik Karlsson & Alex-Xianghua Zhou & Sandra Lunnerdal & Sonja Gustafsson & Byambajav Buyandelger & , 2024. "Adipose stem cells are sexually dimorphic cells with dual roles as preadipocytes and resident fibroblasts," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    8. Julia M. Houthuijzen & Roebi Bruijn & Eline Burg & Anne Paulien Drenth & Ellen Wientjens & Tamara Filipovic & Esme Bullock & Chiara S. Brambillasca & Emilia M. Pulver & Marja Nieuwland & Iris Rink & F, 2023. "CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer," Nature Communications, Nature, vol. 14(1), pages 1-21, December.
    9. Yanfen Xu & Xi Wang & Yuan Li & Yiheng Mao & Yiran Su & Yize Mao & Yun Yang & Weina Gao & Changying Fu & Wendong Chen & Xueting Ye & Fuchao Liang & Panzhu Bai & Ying Sun & Shengping Li & Ruilian Xu & , 2024. "Multimodal single cell-resolved spatial proteomics reveal pancreatic tumor heterogeneity," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    10. Paula Punzon-Jimenez & Alba Machado-Lopez & Raul Perez-Moraga & Jaime Llera-Oyola & Daniela Grases & Marta Galvez-Viedma & Mustafa Sibai & Elena Satorres-Perez & Susana Lopez-Agullo & Rafael Badenes &, 2024. "Effect of aging on the human myometrium at single-cell resolution," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    11. Saba Nayar & Jason D. Turner & Saba Asam & Eanna Fennell & Matthew Pugh & Serena Colafrancesco & Onorina Berardicurti & Charlotte G. Smith & Joe Flint & Ana Teodosio & Valentina Iannizzotto & David H., 2025. "Molecular and spatial analysis of tertiary lymphoid structures in Sjogren’s syndrome," Nature Communications, Nature, vol. 16(1), pages 1-17, December.
    12. Christopher J. Hanley & Sara Waise & Matthew J. Ellis & Maria A. Lopez & Wai Y. Pun & Julian Taylor & Rachel Parker & Lucy M. Kimbley & Serena J. Chee & Emily C. Shaw & Jonathan West & Aiman Alzetani , 2023. "Single-cell analysis reveals prognostic fibroblast subpopulations linked to molecular and immunological subtypes of lung cancer," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    13. Martin Arostegui & R. Wilder Scott & Kerstin Böse & T. Michael Underhill, 2022. "Cellular taxonomy of Hic1+ mesenchymal progenitor derivatives in the limb: from embryo to adult," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    14. Lu Han & Yongxia Wu & Kun Fang & Sean Sweeney & Ulyss K. Roesner & Melodie Parrish & Khushbu Patel & Tom Walter & Julia Piermattei & Anthony Trimboli & Julia Lefler & Cynthia D. Timmers & Xue-Zhong Yu, 2023. "The splanchnic mesenchyme is the tissue of origin for pancreatic fibroblasts during homeostasis and tumorigenesis," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    15. Seongryong Kim & Ji Hyang Jeon & Myeonghwan Kim & Yeji Lee & Yun-Ho Hwang & Myungsun Park & C. Han Li & Taeyoung Lee & Jung-Ah Lee & You-Me Kim & Dokeun Kim & Hyukjin Lee & You-Jin Kim & V. Narry Kim , 2024. "Innate immune responses against mRNA vaccine promote cellular immunity through IFN-β at the injection site," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    16. Lin Wei Tung & Elena Groppa & Hesham Soliman & Bruce Lin & Chihkai Chang & Chun Wai Cheung & Morten Ritso & David Guo & Lucas Rempel & Sarthak Sinha & Christine Eisner & Julyanne Brassard & Kelly McNa, 2023. "Spatiotemporal signaling underlies progressive vascular rarefaction in myocardial infarction," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    17. Hongyu Shen & Xun Huang & Yiheng Zhao & Dongmei Wu & Kaili Xue & Jingfei Yao & Yushuang Wang & Nan Tang & Yifu Qiu, 2022. "The Hippo pathway links adipocyte plasticity to adipose tissue fibrosis," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    18. Xue Yang & Jianming Wang & Chun-Yuan Chang & Fan Zhou & Juan Liu & Huiting Xu & Maria Ibrahim & Maria Gomez & Grace L. Guo & Hao Liu & Wei-Xing Zong & Fredric E. Wondisford & Xiaoyang Su & Eileen Whit, 2024. "Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia in mice," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    19. Swetha Anandhan & Shelley Herbrich & Sangeeta Goswami & Baoxiang Guan & Yulong Chen & Marc Daniel Macaluso & Sonali Jindal & Seanu Meena Natarajan & Samuel W. Andrewes & Liangwen Xiong & Ashwat Nagara, 2024. "TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer," Nature Communications, Nature, vol. 15(1), pages 1-13, December.
    20. E. Koncina & M. Nurmik & V. I. Pozdeev & C. Gilson & M. Tsenkova & R. Begaj & S. Stang & A. Gaigneaux & C. Weindorfer & F. Rodriguez & M. Schmoetten & E. Klein & J. Karta & V. S. Atanasova & K. Grzyb , 2023. "IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer," Nature Communications, Nature, vol. 14(1), pages 1-17, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-42178-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.